Infinity Pharmaceuticals Announces Three Key Strategic Hires

CAMBRIDGE, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Infinity Pharmaceuticals, Inc. (Nasdaq: INFI - News), an innovative cancer drug discovery and development company, announced today the appointments of Gerald Quirk, J.D. as Vice President and General Counsel; Steven Kafka, Ph.D. as Vice President, Strategic Product Planning and Finance; and John Evans as Manager, Investor Relations and Business Development. These key strategic hires are designed to support priority areas for Infinity in its new status as a public company following the completion of its reverse merger with Discovery Partners International, Inc. last week.

Gerald Quirk, J.D., has joined Infinity as Vice President and General Counsel, bringing with him 12 years' experience representing biotechnology companies in connection with securities offerings and SEC compliance activities, mergers and acquisitions, licensing and collaboration agreements, and product commercialization initiatives.

---